Neuland Laboratories shares surged about 7% after the company delivered a blockbuster Q4. Profit leapt seven-fold year-on-year while revenue doubled, pointing to strong momentum across its key segments. Management said the results reflect broad business strength and highlighted continued investments and strategic moves to support future growth. Investors reacted positively to the jump in earnings power.
Swipe through stories, personalise your feed, and save articles for later — all on the app.
